Could an existing drug halt Parkinson’s disease?

A new Parkinson’s study suggests that drugs for treating a rare genetic disorder may be effective in targeting toxic alpha-synuclein clusters in neurons.

This entry was posted in Headlines, News & Events. Bookmark the permalink.

Leave a Reply